This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université Paris Descartes. Active years: 2012.
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 132 
Years Active: 2012
Title: Jacques Lependu: Innovator in Pharmaceutical Chemistry
Introduction
Jacques Lependu is a notable inventor based in Nantes, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on α-galactoceramide analogs. His research has implications for the development of anti-cancerous pharmaceutical compositions.
Latest Patents
Lependu holds a patent for α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them. The invention focuses on the synthesis of α-galactoceramide analogs using unsaturated intermediate compounds, which allows for their production through a metathesis reaction. These analogs serve as active ingredients in pharmaceutical compositions, especially those aimed at combating cancer.
Career Highlights
Throughout his career, Jacques Lependu has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris Descartes. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Lependu has collaborated with notable colleagues, including Didier Dubreuil and Muriel Pipelier. These partnerships have fostered a collaborative environment that enhances innovation in their respective fields.
Conclusion
Jacques Lependu's contributions to pharmaceutical chemistry, particularly through his patent on α-galactoceramide analogs, highlight his role as an innovator in the industry. His work continues to influence the development of effective anti-cancer treatments.